HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain Metastases.
Michel A, Oppong MD, Rauschenbach L, Pierscianek D, Dinger TF, Schmidt T, Hense J, Pöttgen C, Kimmig R, Ahmadipour Y, Özkan N, Müller O, Junker A, Sure U, Jabbarli R, El Hindy N.
Michel A, et al.
World Neurosurg. 2021 Aug;152:e332-e343. doi: 10.1016/j.wneu.2021.05.096. Epub 2021 May 29.
World Neurosurg. 2021.
PMID: 34062302